Engineering a Potent Anti-MRSA Agent: The Development and Characterization of Chimeric Endolysin ZAM-MSC.

Key Points

• ZAM-MSC demonstrates significant effectiveness as an anti-MRSA agent, likely improving treatment options.
• Key evidence shows ZAM-MSC achieved notable antibacterial activity in laboratory tests against MRSA strains.
• Through a combination of computational precision and rigorous experimental validation, ZAM-MSC was engineered to combat MRSA effectively.
• If successful, ZAM-MSC may transform treatment approaches for MRSA infections, but clinical trials will be necessary.